Peer-reviewed publications, policy papers, conference presentations and ongoing research — at the intersection of global health systems, health economics, and pharmaceutical access.
How do low- and middle-income countries finance the transition to UHC? What works, what fails, and what the evidence says about sustainable health financing in resource-constrained settings.
The intersection of antibiotic access, antimicrobial resistance, and pharmaceutical supply chain governance in Africa — with a focus on policy-relevant interventions.
Extending the NHS social prescribing evidence base to include cross-continental comparisons with community health worker models in sub-Saharan Africa and primary care reform in LMICs.
The adequacy of existing metrics (DALYs, QALYs, equity-weighted cost-effectiveness) for capturing health inequity across different contexts and income settings.
Systematic comparison of health system architecture, financing, and outcomes across Nigeria, China, and the UK — identifying transferable lessons and structural differences.
The evidence base for NHS Scotland reform, workforce development, integrated care systems, and the role of pharmacy in primary care.
Beulah is open to co-authorship, data collaboration, systematic review contributions, and joint policy paper proposals aligned with her four research pillars.
Get in Touch